Literature DB >> 20445461

Left atrial asynchrony is a major predictor of 1-year recurrence of atrial fibrillation after electrical cardioversion.

Elisa Rondano1, Gabriele Dell'Era, Giuseppe De Luca, Cristina Piccinino, Giorgio Bellomo, Paolo N Marino.   

Abstract

BACKGROUND: The level of atrial mechanical asynchrony may vary within the atrial fibrillation population and this may have pathophysiological relevance.
OBJECTIVE: We sought to verify whether the degree of left-atrial mechanical asynchrony associated with atrial fibrillation is a predictor of arrhythmia recurrence after restoration of sinus rhythm with electrical cardioversion. METHODS AND
RESULTS: Left atrial volume was calculated, whereas two-dimensional (2D) strain (speckle tracking technique) was used to estimate peak and standard deviation (SD) of time-to-peak of deformation of six segments arbitrarily identified along the perimeter of the cavity, imaged in apical four-chamber view. Left atrial mechanical asynchrony was quantified according to quartiles of time-to-peak SD assuming that larger values would identify higher grades of asynchrony. A total of 130 patients undergoing cardioversion for atrial fibrillation were prospectively enrolled. Time-to-peak SD was inversely related with peak strain (P < 0.001). No differences were observed among groups in terms of clinical, therapeutical and additional echocardiographic variables. At 1-year atrial fibrillation was observed in 53% of patients, with time-to-peak SD linearly related to atrial-fibrillation recurrence (P = 0.014). At multivariate analysis only time-to-peak SD (P = 0.032), but not atrial volume (P = 0.075), was identified as an independent predictor of fibrillation recurrence.
CONCLUSION: This is the first study showing that left atrial asynchrony, quantified as time-to-peak SD of regional atrial strains before electrical cardioversion, is a major independent predictor of fibrillation recurrence in patients back to sinus-rhythm postprocedure.

Entities:  

Mesh:

Year:  2010        PMID: 20445461     DOI: 10.2459/JCM.0b013e32833757b5

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  6 in total

1.  Analysis of electrical and mechanical left atrial properties in patients with persistent atrial fibrillation.

Authors:  Anna Degiovanni; Miriam Bortnik; Gabriele Dell'Era; Virginia Bolzani; Eraldo Occhetta; Giorgio Bellomo; Paolo Marino
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-29       Impact factor: 2.357

Review 2.  Assessment of Left Atrial Function by Echocardiography: Novel Insights.

Authors:  Brian D Hoit
Journal:  Curr Cardiol Rep       Date:  2018-08-27       Impact factor: 2.931

3.  Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.

Authors:  Mohammadali Habibi; Joao A C Lima; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; Kotaro Fukumoto; David Spragg; Hiroshi Ashikaga; John Rickard; Joseph E Marine; Hugh Calkins; Saman Nazarian
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

4.  Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation.

Authors:  Jakob Schroder; Olivier Bouaziz; Bue Ross Agner; Torben Martinussen; Per Lav Madsen; Dana Li; Ulrik Dixen
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

Review 5.  Methodological Gaps in Left Atrial Function Assessment by 2D Speckle Tracking Echocardiography.

Authors:  Roxana Cristina Rimbaş; Raluca Elena Dulgheru; Dragoş Vinereanu
Journal:  Arq Bras Cardiol       Date:  2015-12       Impact factor: 2.000

6.  Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation.

Authors:  Paweł Wałek; Elzbieta Ciesla; Iwona Gorczyca; Beata Wożakowska-Kapłon
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.